Editor’s Choice for May 2018
Published: 21 May 2018
Views: 1422
Prof Gordon McVie - Founding Editor, ecancer
- Categories:
- Brain & nervous system
- Breast
- Melanoma & skin
- Neuroendocrine
- Ovary & gynaecology
- Prostate & urology
- Nutrition & wellbeing
- Patient empowerment
- Personalised medicine
- Psychosocial
- Care
- Economics
- Low-middle income
- Medicines
- Organisation of cancer
- Prevention
- R&D
- Regulatory
- Science domains
- Social determinants
- Technology & innovation
- Training & development
- Bioinformatics
- Biology
- Biomarkers
- Causes of cancer
- Control, survivorships & outcomes
- Detection, diagnosis & prognosis
- Diagnostics
- Epidemiology & prevention
- Antibodies & immunotherapy
- Cell therapy & stem cells
- Complications
- Cytotoxics
- Drug development
- Hormones/endocrine
- Radiotherapy
- Supportive care
- Surgery
- Targeted molecules
- Vaccines & virus
Related Videos
Breast Cancer at ASCO 2020 - AORTIC African Cancer Dialogues
Host: Dr. Miriam Mutebi, Speakers: Dr. Verna Vanderpuye, Dr. Sitna Mwanzi
6 Aug 2020
Future perspective of CDH1 mutation in gastric and breast cancers
Dr. Giovanni Corso - University of Milan, Italy, Meeting president
22 Jul 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial c...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
30 Jun 2020
Advances in breast cancer treatment over the last 20 years
Dr Philip Poortmans - Institut Curie, Paris, France
27 Jan 2020
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
30 Sep 2019
How will ASCO combat cancer disparities?
Dr Eduardo Cazap, Dr Richard Schilsky
21 Jun 2019
The global program of the American Cancer Society
Dr Meg O'Brien - American Cancer Society, Atlanta, USA
5 Jun 2019
Latest in ovarian cancer treatment
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
24 May 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
14 Feb 2019
